Literature DB >> 16469028

Risk factors for Peyronie's disease: a case-control study.

Milan D Bjekic1, Hristina D Vlajinac, Sandra B Sipetic, Jelena M Marinkovic.   

Abstract

OBJECTIVE: To test some hypotheses about risk factors for Peyronie's disease (PD). PATIENTS AND METHODS: In a case-control study, 82 patients with PD, consecutively diagnosed at the first author's institution, were compared with 246 men visiting the same institution for dermatological diseases. Univariate and multivariate logistic regression analyses were used to assess the data.
RESULTS: From the multivariate logistic regression analysis the risk factors for PD were: a history of genital and/or perineal injuries, transurethral prostatectomy, cystoscopy, diabetes mellitus, hypertension, lipoma, propranolol in therapy, Dupuytren's contracture in the medical history, ever having smoked, alcohol consumption, fibromatous lesions of the genital tract of the partner, and surgical intervention on the genital tract of the partner.
CONCLUSION: The results of the present study are in line with the hypothesis that, in addition to genetic predisposition, trauma of the penis and systemic vascular diseases are risk factors for PD. Smoking and alcohol consumption also seem to have some role in the development of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16469028     DOI: 10.1111/j.1464-410X.2006.05969.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  26 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

Review 2.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

Review 3.  Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects.

Authors:  María Alejandra Egui Rojo; Ignacio Moncada Iribarren; Joaquín Carballido Rodriguez; Juan Ignacio Martinez-Salamanca
Journal:  Ther Adv Urol       Date:  2014-10

Review 4.  The Genetic Basis of Peyronie Disease: A Review.

Authors:  Amin S Herati; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-01-08

Review 5.  Pharmacological Management of Peyronie's Disease.

Authors:  Landon W Trost; Serap Gur; Wayne J G Hellstrom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Significant familial clustering of Peyronie's disease in close and distant relatives.

Authors:  Kristina L Allen-Brady; Michael B Christensen; Ashlynn D Sandberg; Alexander W Pastuszak
Journal:  Andrology       Date:  2022-07-13       Impact factor: 4.456

7.  Diagnosis and treatment patterns of Peyronie's disease among different racial, ethnic, and regional groups in the Veterans Affairs healthcare system.

Authors:  Sirpi Nackeeran; Isaac Zucker; Iakov Efimenko; Alexander Weber; Scott C Brown; Ranjith Ramasamy; Thomas Masterson
Journal:  Int J Impot Res       Date:  2022-09-23       Impact factor: 2.408

8.  Penile traction therapy and Peyronie's disease: a state of art review of the current literature.

Authors:  Eric Chung; Gerald Brock
Journal:  Ther Adv Urol       Date:  2013-02

9.  Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in Peyronie's disease: a new diagnostic approach to predict the stage of the disease?

Authors:  Esther Garcia Rojo; Borja García Gómez; Rocio Santos-Pérez de la Blanca; Celeste Manfredi; Manuel Alonso Isa; José Medina Polo; Alfredo Rodríguez Antolín; Javier Romero Otero
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

Review 10.  Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.

Authors:  Fuxun Zhang; Feng Qin; Jiuhong Yuan
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.